Abstract:The 3T3-L1 adipocyte differentiation system is a reliable in vitro model for adipogenesis in vivo. Under the controlled conditions of cell culture, 3T3-L1 preadipocytes can be induced (with appropriate hormonal agents) to differentiate into cells that have the biochemical and morphological characteristics of tissue adipocytes. We have identified, cloned, and characterized a number of adipocyte genes that are coordinately activated during differentiation and contribute to acquisition of the adipocyte phenotype. C/EBPα serves as a pleiotropic transcriptional activator of these and many other adipocyte genes. Expression of C/EBPα is not only required for, but is sufficient (in combination with PPARγ) to activate the differentiation program of 3T3-L1 preadipocytes without the use of hormonal agents. In view of the importance of C/EBPα in adipocyte differentiation, we have begun to characterize the promoter of the C/EBPα gene. In addition to a C/EBP regulatory element in the proximal promoter of the gene, we have identified three repressor binding sites. A differentially expressed nuclear factor that binds to two of these sites has been isolated and characterized. This factor, referred to as CUP (C/EBPα Undifferentiated Protein), is expressed by preadipocytes but not adipocytes. Both the mouse and human C/EBPα genes possess two CUP binding sites, one in the 5′-flanking and another in the 5′-untranslated region of the genes. Mutation of either CUP site individually has little effect on reporter gene transcription mediated by the promoter; however, when both CUP sites are mutated marked synergistic “derepression” occurs. We have purified CUP from 3T3-L1 preadipocytes and shown it to be an isoform of the transcription factor AP-2α. Forced expression of the AP-2α1 isoform in adipocytes, which normally do not express this factor, inhibits reporter gene transcription mediated by the C/EBPα promoter. Our findings indicate that CUP/AP-2α is a repressor of the C/EBPα gene promoter and suggest that this factor maintains the gene in a repressed state prior to differentiation. A binding site (a GC box) for another repressor has been identified at the 5′-end of the C/EBP regulatory element in the C/EBPα promoter. The transcription factor Sp1, which is expressed by preadipocytes, was found to bind at this site. By binding at this site, Sp1 sterically can block access to the C/EBP binding site by members of the C/EBP family. Thus, transcriptional activation of the C/EBPα a gene by C/EBPβ (and possibly C/EBPδ), which is thought to occur early in the adipocyte differentiation program, would be prevented. Consistent with this view, transactivation of C/EBPα promoter by C/EBPβ is inhibited by Sp1. Preliminary evidence indicates that the differentiation inducers increase the rate of turnover of Sp1. Lowering the Sp1 level early in the differentiation program would facilitate binding of C/EBPβ to the C/EBP regulatory element and, thereby, transcriptional activation of the C/EBPα gene.

Molecular stop signs: regulation of cell-cycle arrest by C/EBP transcription factors

The C/EBP family of transcription factors: a paradigm for interaction between gene expression and proliferation control

Dominant-negative C/EBP Disrupts Mitotic Clonal Expansion and Differentiation of 3T3-L1 Preadipocytes

Role Of Cdk2 In The Sequential Phosphorylation/Activation Of C/Ebp Beta During Adipocyte Differentiation

Regulation of the cdk inhibitor p21 gene during cell cycle progression is under the control of the transcription factor E2F

C/EBPβ Is a Transcriptional Regulator of Wee1 at the G2/M Phase of the Cell Cycle

Transcriptional and translational regulation of CCAAT/Enhancer Binding Protein β expression by P53

Regulation of C/EBPbeta1 by Ras in mammary epithelial cells and the role of C/EBPbeta1 in oncogene-induced senescence

Role of C/Ebp Homologous Protein (Chop-10) in the Programmed Activation of Ccaat/Enhancer-Binding Protein-Beta During Adipogenesis

Role of the CCAAT Enhancer Binding Proteins (c/ebps) in Adipocyte Differentiation

Upregulation of C/EBPα Contributes to Colorectal Cancer Growth, Metastasis and Indicates Poor Survival Outcome.

The HBP1 Transcriptional Repressor and the P38 MAP Kinase: Unlikely Partners in G1 Regulation and Tumor Suppression

Phosphorylation Prevents C/EBPβ from the Calpain-Dependent Degradation

An intermediate Rb–E2F activity state safeguards proliferation commitment

Involvement of the cell-cycle inhibitor Cip1/WAF1 and the E1A-associated p300 protein in terminal differentiation.

The Adipocyte Differentiation Program: RepressiodDerepression of the C/EBPα Gene

Molecular competition in G1 controls when cells simultaneously commit to terminally differentiate and exit the cell-cycle

Cooperation Between The Cdk Inhibitors P27(Kip1) And P57(Kip2) In The Control Of Tissue Growth And Development

Cell-cycle inhibitors: three families united by a common cause

Sequential Phosphorylation Of Ccaat Enhancer-Binding Protein Beta By Mapk And Glycogen Synthase Kinase 3 Beta Is Required For Adipogenesis

Transcriptional Activation of Histone H4 by C/EBPβ During the Mitotic Clonal Expansion of 3T3-L1 Adipocyte Differentiation.